低罹患国における結核専門診療所の20年間の経験
Sandra Pérez-Recio1, Maria D Grijota-Camino2, Jordi Guardiola3,4
1Tuberculosis Unit, Department of Infectious Diseases, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
まとめ
生物学的治療 (BioT) の前に結核 (TB) のスクリーニングが不可欠です. インターフェロンγ放出測定法 (IGRA) の単一の検査は有効であり,陰性検査の後の定期的な再スクリーニングは推奨されません.
科学分野:
- 免疫学
- 感染症
- 薬理学について
背景:
- 生物学的治療法 (BioT) は,結核 (TB) の再活性化のリスクを増加させる可能性があります.
- 効果的なスクリーニング戦略は,このリスクを軽減するために不可欠です.
- QuantiFERON- TB (QFT) Goldのようなインターフェロンγ放出アッセイ (IGRA) のスクリーニングにおける役割については,さらなる評価が必要である.
研究 の 目的:
- 生物治療を受ける患者の結核のリスクを評価する.
- 単独のスクリーニングテストとしてQFT Goldの有効性を評価する.
- 定期的な再検査が必要かどうかを判断する.
主な方法:
- 4つの異なる戦略を用いて,BioTを開始した1,368人の患者をスクリーニングした.
- 戦略には,様々な組み合わせで結核素皮膚検査 (TST) とQFTゴールド (インチューブまたはプラス) が含まれていた.
- 結核感染と診断された患者は予防療法を受けた.
主要な成果:
- 異なるスクリーニング戦略で結核感染の流行率が著しく低下した (40. 8% から 14. 8%).
- 追跡期間中に結核を発症したのは患者の0. 8%のみで,すべての症例は最初の1年以内に発症した.
- スクリーニング期間間には,結核無生存期における有意な差は認められなかった.
結論:
- BioTに関連した結核のリスクを減らすことはできますが,完全に予防することはできません.
- 単一のQFTゴールドテストは効果的なスクリーニング方法です.
- 定期的な結核再検査は,前バイオテストで陰性が出た場合では不要です.
さらに関連する動画
関連する概念動画
Pulmonary Tuberculosis V
236
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
236
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis IV
196
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
196
Transmission-based Precautions II: Airborne and Protective Environment
1.5K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K
Pulmonary Tuberculosis II
339
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
339
Pulmonary Tuberculosis III
438
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
438


